|1.||Vidal-Bugallo, J B: 1 article (05/2013)|
|2.||Gimeno, L: 1 article (05/2013)|
|3.||Eguia, J: 1 article (05/2013)|
|4.||Bernardo-Pisa, M V: 1 article (05/2013)|
|5.||Alvarez-López, M R: 1 article (05/2013)|
|6.||García-Alonso, A M: 1 article (05/2013)|
|7.||Muro, M: 1 article (05/2013)|
|8.||Martínez-Banaclocha, H: 1 article (05/2013)|
|9.||Salgado, G: 1 article (05/2013)|
|10.||Campillo, J A: 1 article (05/2013)|
05/01/1990 - "Forty South African patients with homozygous deficiency of the sixth component of complement (C6) have been identified in an area where group B meningococcal meningitis is endemic; 22 of the 24 proband cases presented with recurrent meningococcal meningitis. "
08/01/1983 - "Meningococcal meningitis and complement (C6) deficiency."
10/17/1981 - "[Recurrent meningococcal meningitis associated with complement C6 deficiency (author's transl)]."
10/01/1979 - "A 51/2-year-old black girl with recurrent meningococcal meningitis and absence of the sixth component of complement (C6) is reported. "
05/25/2013 - "In this work we report the immunochemical and molecular characterization of complement C6 deficiency in a Spanish patient showing no detectable functional activity of either the classical or alternative complement pathways and reporting a history of several episodes of meningococcal meningitis. "
|3.||Schizophrenia (Dementia Praecox)
01/01/1992 - "Polymorphic variants of C3, BF and C6 complement factors have been investigated in schizophrenic patients subdivided according to the existence or not of a family history of both schizophrenia and other psychiatric disorders. "
01/01/1985 - "C3 and C6 complement types in schizophrenia."
|4.||Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
|5.||Oculocutaneous Albinism (Albinism, Yellow Mutant)
|1.||Complement System Proteins (Complement)
|2.||Complement Membrane Attack Complex (Membrane Attack Complex)
|3.||Complement Factor B (Factor B)
|5.||Fibrinogen (Factor I)
|6.||Factor XIII (Coagulation Factor XIII)
|9.||monoclonal antibody ch14.18